Literature DB >> 21463341

Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.

Sayaka Inokuchi1, Hidekazu Tsukamoto, EekJoong Park, Zhang-Xu Liu, David A Brenner, Ekihiro Seki.   

Abstract

BACKGROUND: Excessive alcohol intake causes an increase in intestinal permeability that induces translocation of gut-derived lipopolysaccharide (LPS) to the portal vein. Increased LPS in the portal vein stimulates Kupffer cells through Toll-like receptor (TLR) 4 in the liver. Activated TLR4 signaling in Kupffer cells induces various inflammatory mediators including TNF-α, IL-1β, and reactive oxygen species, resulting in liver injury. Hepatic stellate cells (HSCs) also express TLR4. This study investigates whether TLR4 on bone marrow (BM)-derived cells, including Kupffer cells, or non-BM-derived endogenous liver cells, including HSCs, contributes to the progression of alcohol-induced steatohepatitis and fibrogenesis in mice.
METHODS: TLR4 BM chimera (wild-type [WT] mice with TLR4(-/-) BM or TLR4(-/-) mice with WT BM) were generated by the combination of liposomal clodronate injection with whole body irradiation and BM transplantation, followed by treatment with intragastric alcohol feeding.
RESULTS: WT mice transplanted with WT BM exhibited liver injury, steatosis, inflammation, and a fibrogenic response. Conversely, TLR4(-/-) mice with TLR4(-/-) BM displayed less steatosis, liver injury, and inflammation. Notably, steatosis, macrophage infiltration, and alanine aminotransferase levels in both TLR4-chimeric mice showed intermediate levels between WT mice transplanted with WT BM and TLR4(-/-) mice transplanted with TLR4(-/-) BM. Hepatic mRNA expression of fibrogenic markers (collagen α1(I), TIMP1, TGF-β1) and inflammatory cytokines (IL-1β, IL-6) were markedly increased in WT mice with WT BM, but there was less of an increase in both TLR4-chimeric mice and in TLR4(-/-) mice transplanted with TLR4(-/-) BM.
CONCLUSIONS: TLR4 signaling in both BM-derived and non-BM-derived liver cells is required for liver steatosis, inflammation, and a fibrogenic response after chronic alcohol treatment.
Copyright © 2011 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21463341      PMCID: PMC3131439          DOI: 10.1111/j.1530-0277.2011.01487.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  37 in total

1.  Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice.

Authors:  T Uesugi; M Froh; G E Arteel; B U Bradford; R G Thurman
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

2.  Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

Authors:  Kouichi Miura; Yuzo Kodama; Sayaka Inokuchi; Bernd Schnabl; Tomonori Aoyama; Hirohide Ohnishi; Jerrold M Olefsky; David A Brenner; Ekihiro Seki
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

Review 3.  The liver as a lymphoid organ.

Authors:  Ian Nicholas Crispe
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 4.  How is the liver primed or sensitized for alcoholic liver disease?

Authors:  H Tsukamoto; Y Takei; C J McClain; S Joshi-Barve; D Hill; J Schmidt; I Deaciuc; S Barve; A Colell; C Garcia-Ruiz; N Kaplowitz; J C Fernandez-Checa; H Yokoyama; Y Okamura; Y Nakamura; H Ishii; R K Chawla; S Barve; S Joshi-Barve; W Watson; W Nelson; M Lin; M Ohata; K Motomura; N Enomoto; K Ikejima; T Kitamura; H Oide; M Hirose; B U Bradford; C A Rivera; H Kono; S Peter; S Yamashina; A Konno; M Ishikawa; H Shimizu; N Sato; R Thurman
Journal:  Alcohol Clin Exp Res       Date:  2001-05       Impact factor: 3.455

Review 5.  Alcoholic liver disease and the gut-liver axis.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

6.  Enteric dysbiosis associated with a mouse model of alcoholic liver disease.

Authors:  Arthur W Yan; Derrick E Fouts; Johannes Brandl; Peter Stärkel; Manolito Torralba; Eckart Schott; Hide Tsukamoto; Karen E Nelson; David A Brenner; Bernd Schnabl
Journal:  Hepatology       Date:  2010-12-10       Impact factor: 17.425

Review 7.  Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury.

Authors:  N Enomoto; K Ikejima; B U Bradford; C A Rivera; H Kono; M Goto; S Yamashina; P Schemmer; T Kitamura; H Oide; Y Takei; M Hirose; H Shimizu; A Miyazaki; D A Brenner; N Sato; R G Thurman
Journal:  J Gastroenterol Hepatol       Date:  2000-03       Impact factor: 4.029

Review 8.  Toll-like receptor 4 and hepatic fibrogenesis.

Authors:  Jean-Philippe Pradere; Juliane S Troeger; Dianne H Dapito; Ali A Mencin; Robert F Schwabe
Journal:  Semin Liver Dis       Date:  2010-07-21       Impact factor: 6.115

9.  CCR1 and CCR5 promote hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele De Minicis; Geum-Youn Gwak; Johannes Kluwe; Sayaka Inokuchi; Christina A Bursill; Josep M Llovet; David A Brenner; Robert F Schwabe
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

10.  CCR2 promotes hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele de Minicis; Sayaka Inokuchi; Kojiro Taura; Katsumi Miyai; Nico van Rooijen; Robert F Schwabe; David A Brenner
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

View more
  80 in total

Review 1.  Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

Authors:  Wonhyo Seo; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

2.  Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.

Authors:  Gail A Cresci; Bryan Glueck; Megan R McMullen; Wei Xin; Daniella Allende; Laura E Nagy
Journal:  J Gastroenterol Hepatol       Date:  2017-09       Impact factor: 4.029

Review 3.  Alcoholic liver disease: the gut microbiome and liver cross talk.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Bernd Schnabl
Journal:  Alcohol Clin Exp Res       Date:  2015-05       Impact factor: 3.455

4.  Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria.

Authors:  Shuang Liang; Zhenyu Zhong; So Yeon Kim; Ryosuke Uchiyama; Yoon Seok Roh; Hiroshi Matsushita; Roberta A Gottlieb; Ekihiro Seki
Journal:  J Biol Chem       Date:  2019-06-24       Impact factor: 5.157

5.  Alcohol-induced adipose tissue macrophage phenotypic switching is independent of myeloid Toll-like receptor 4 expression.

Authors:  Melissa A Fulham; Anuradha Ratna; Rachel M Gerstein; Evelyn A Kurt-Jones; Pranoti Mandrekar
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-03       Impact factor: 4.249

Review 6.  Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.

Authors:  Laura E Nagy; Wen-Xing Ding; Gail Cresci; Paramananda Saikia; Vijay H Shah
Journal:  Gastroenterology       Date:  2016-02-23       Impact factor: 22.682

7.  TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration.

Authors:  Yoon Seok Roh; Bi Zhang; Rohit Loomba; Ekihiro Seki
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-04-30       Impact factor: 4.052

8.  Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease.

Authors:  Jan Petrasek; Arvin Iracheta-Vellve; Banishree Saha; Abhishek Satishchandran; Karen Kodys; Katherine A Fitzgerald; Evelyn A Kurt-Jones; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2015-05-01       Impact factor: 4.962

9.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

10.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.